Tech companies Mitsui and NVIDIA have joined forces to develop what they say is the world’s first generative artificial intelligence supercomputer designed for use in phar
UK biotech Exscientia has taken a step towards its goal of having four drug candidates in clinical trials next year, after inheriting two precision oncology candidates tha
Inato has raised $20 million in early-stage financing to support the continued development of its clinical trial marketplace, which connects sponsors with its network of t